Skylar Jeremias

FDA approvals since the last Skin of Color Update expand topical and biologic options for various dermatological conditions, benefiting patients with skin of color.

The FDA has approved a second generic version of oral mifepristone, used to terminate pregnancy, after determining it is identical to the branded drug.

Programs such as Meds to Bed can work in tandem with retail pharmacies to offer accessible medications for patients.

Despite an executive order aimed at addressing homelessness in the US, defunding vital programs could spell difficulty in helping the homeless.

Prior authorizations can affect both health system operations and worsen physician burnout.

At the European Respiratory Society Congress, experts explored the critical connections between climate change, respiratory health, and health equity, highlighting the importance of integrated solutions, local action, and education.

Experts at the ERS Congress 2025 highlighted threats to scientific integrity from misinformation, political interference, and predatory publishing in health research.

Experts at European Respiratory Society (ERS) Congress 2025 highlight the critical link between reduced lung function and increased cardiovascular disease risk, urging early intervention and awareness.

Laxmi Patel urges rural hospitals to align leadership early and build logic models to show how transformation funds can drive access, equity, and sustainability.

Digital health technologies enhance respiratory care through decentralized clinical trials and home monitoring, expanding access and improving patient engagement.

Davey Daniel, MD, shares strategies to prevent bias in artificial intelligence (AI) and outlining future opportunities for its adoption in precision oncology.

Nerandomilast shows promise in treating progressive pulmonary fibrosis, demonstrating significant benefits in lung function and safety in recent trials.

Experts debate e-cigarettes' role in smoking cessation and public health at ERS Congress 2025, weighing benefits against potential risks and regulatory needs.

Experts reveal the health risks of indoor air pollution from biomass fuels and cleaning products, emphasizing prevention strategies for respiratory diseases.

Broader integration of artificial intelligence (AI) in precision oncology depends on overcoming barriers such as trust and transparency, according to Davey Daniel, MD.

Blood Cancer United, formerly Leukemia & Lymphoma Society, aims to enhance awareness and support for blood cancer patients during Blood Cancer Awareness Month.

High discontinuation rates of semaglutide among older adults with diabetes reveal challenges in long-term adherence and highlight the need for improved support strategies.

Proposed Medicaid cuts threaten children's health coverage, exacerbating existing gaps and impacting access to care for vulnerable populations.

The relationship between caffeine and rheumatoid arthritis has been inconsistent across prior studies.

Discover groundbreaking discussions at the European Respiratory Society Congress 2025, focusing on severe asthma, e-cigarette debates, and global health equity in respiratory care.

Teclistamab shows promising real-world effectiveness and safety in older adults with relapsed/refractory multiple myeloma (R/R MM), matching clinical trial outcomes.

On this episode of Managed Care Cast, experts discuss the practical implications of bias in electronic health care records.

New research reveals that changes in normal-appearing white and gray matter significantly impact MS progression, challenging traditional lesion-focused views.

Refat Rasul Srejon, MPH, recommends employer coverage for substance use care and follow-up, plus research on local treatment and drug trends.

The American Heart Association (AHA) launched a news initiative to address challenges with in-hospital care for patients with different types of heart failure.

The LINKER-SMM1 trial evaluates linvoseltamab's safety and efficacy in high-risk smoldering multiple myeloma, aiming to delay disease progression.

Iron dysregulation significantly impacts multiple sclerosis progression, linking iron levels to neuroinflammation, demyelination, and potential therapeutic strategies.

Despite higher burden of metabolic issues, individuals with HIV were not more metabolically ill.

By 2040, advanced metabolic dysfunction–associated steatohepatitis (MASH) is projected to rise by at least 20% in the 9 countries assessed.

A new report from the National Alliance calls for data transparency and PBM reform to combat rising care costs, enhance equity, and improve well-being.